{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:31:59Z","timestamp":1789968719290,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2015.08.089","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T15:03:06Z","timestamp":1439305386000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Uric acid and xanthine oxidase in heart failure \u2014 Emerging data and therapeutic implications"],"prefix":"10.1016","volume":"213","author":[{"given":"Wolfram","family":"Doehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa A.","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.08.089_bb0005","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","article-title":"Metabolic impairment in heart failure. The myocardial and systemic perspective","volume":"64","author":"Doehner","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","article-title":"Cachexia as a major public health problem: frequent, costly, and deadly","volume":"4","author":"Farkas","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13539-013-0109-7","article-title":"J Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure","volume":"4","author":"Habedank","year":"2013","journal-title":"Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2001.114367","article-title":"Uric acid in cachectic and non-cachectic patients with chronic heart failure: relationship to leg vascular resistance","volume":"141","author":"Doehner","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0025","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/oxfordjournals.eurheartj.a015352","article-title":"Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure","volume":"18","author":"Leyva","year":"1997","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0030","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0026-0495(98)90293-1","article-title":"Uric acid in chronic heart failure: a measure of the anaerobic threshold","volume":"47","author":"Leyva","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0026-0495(98)90026-9","article-title":"The glycolytic pathway to coronary heart disease: a hypothesis","volume":"47","author":"Leyva","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.RES.85.5.437","article-title":"Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure","volume":"85","author":"Ekelund","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0045","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/hc4501.098928","article-title":"Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy","volume":"104","author":"Cappola","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cardfail.2006.05.005","article-title":"The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study","volume":"12","author":"Cingolani","year":"2006","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11739-013-1016-9","article-title":"Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study","volume":"9","author":"Cicero","year":"2014","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0060","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000144303.24894.1C","article-title":"Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction","volume":"110","author":"Engberding","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/hrt.2004.040477","article-title":"Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure","volume":"91","author":"Gavin","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0075","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1742-1241.2009.02118.x","article-title":"Association between allopurinol and mortality in heart failure patients: a long-term follow-up study","volume":"63","author":"Wei","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0080","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2005.10.033","article-title":"Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure","volume":"115","author":"Jankowska","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejheart.2006.09.001","article-title":"Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients","volume":"9","author":"Pascual-Figal","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejim.2008.04.007","article-title":"Hyperuricemia in acute heart failure. More than a simple spectator?","volume":"20","author":"Alimonda","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1751-7133.2010.00144.x","article-title":"Uric acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level","volume":"16","author":"Kim","year":"2010","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0105","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","article-title":"Gout, allopurinol use, and heart failure outcomes","volume":"170","author":"Thanassoulis","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1751-7133.2011.00200.x","article-title":"Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis","volume":"17","author":"Tamariz","year":"2011","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0115","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/eurjhf\/hfr030","article-title":"Predictors of clinical outcomes in elderly patients with heart failure","volume":"13","author":"Manzano","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13539-013-0120-z","article-title":"Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults","volume":"5","author":"Fragala","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0130","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"OPT-CHF investigators. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCHEARTFAILURE.113.000394","article-title":"Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study","volume":"6","author":"Givertz","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0140","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/S0021-9258(18)91929-0","article-title":"The reduction of cytochrome c by milk xanthine oxidase","volume":"243","author":"McCord","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0145","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/0006-2952(80)90107-0","article-title":"Liver xanthine oxidase increase in mice in three pathological models. A possible defence mechanism","volume":"29","author":"Tubaro","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13539-012-0097-z","article-title":"Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis","volume":"4","author":"Scott","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0155","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0735-1097(01)01643-6","article-title":"Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease","volume":"38","author":"Maxwell","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0160","first-page":"193","article-title":"Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: an immunocytochemical study","volume":"25","author":"Ashraf","year":"1993","journal-title":"J. Submicrosc. Cytol. Pathol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejheart.2007.03.006","article-title":"Uric acid as a prognostic marker in acute heart failure \u2014 new expectations from an old molecule","volume":"9","author":"Doehner","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0170","first-page":"68","article-title":"Changes in xanthine oxidase activity in patients with circulatory failure","volume":"61","author":"Bakhtiiarov","year":"1989","journal-title":"Ter. Arkh."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0175","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","article-title":"Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 207A","key":"10.1016\/j.ijcard.2015.08.089_bb0180","article-title":"Elevated plasma xanthine oxidase activity in chronic heart failure: source of increased oxygen radical load and effect of allopurinol in a placebo controlled, double blinded treatment study","volume":"42","author":"Doehner","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13539-014-0152-z","article-title":"Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones","volume":"5","author":"Josiak","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0190","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology\u2014update 2014","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers\u2014update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0205","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0210","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.biocel.2013.04.025","article-title":"Muscle wasting in heart failure: an overview","volume":"45","author":"von Haehling","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-014-0132-3","article-title":"From sarcopenia to frailty: a road less traveled","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semnephrol.2011.08.007","article-title":"Xanthine oxidaseand uric acid in cardiovascular disease: clinical impact and therapeutic options","volume":"31","author":"Doehner","year":"2011","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0220","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.ATV.0000258415.32883.bf","article-title":"Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease","volume":"27","author":"Landmesser","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0230","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.freeradbiomed.2005.06.004","article-title":"Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease","volume":"39","author":"Baldus","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0235","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/clpt.2010.116","article-title":"Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol","volume":"88","author":"von Haehling","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0245","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.CIR.103.5.750","article-title":"Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure","volume":"103","author":"Ukai","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0250","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.27494","article-title":"Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia","volume":"131","author":"Springer","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0255","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.ijcard.2013.05.063","article-title":"The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy","volume":"168","author":"Springer","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13539-014-0157-7","article-title":"Muscle wasting: an overview of recent developments in basic research","volume":"5","author":"Palus","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"P\u00f6tsch","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia\u2013cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13539-012-0084-4","article-title":"Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in rats","volume":"4","author":"Peter","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","article-title":"Are we closer to having drugs to treat muscle wasting disease?","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13539-014-0136-z","article-title":"Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies","volume":"5","author":"Ebner","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-014-0138-x","article-title":"An overview of amines as nutritional supplements to counteract cancer cachexia","volume":"5","author":"de Campos-Ferraz","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13539-012-0099-x","article-title":"Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case\u2013control study","volume":"4","author":"Omlin","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13539-014-0162-x","article-title":"Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management","volume":"5","author":"Wakabayashi","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13539-014-0160-z","article-title":"Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?","volume":"5","author":"Rhee","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-014-0140-3","article-title":"Anabolic exercise in haemodialysis patients: a randomised controlled pilot study","volume":"5","author":"Kirkman","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2006.05.003","article-title":"Uric acid in CHF: marker or player in a metabolic disease?","volume":"115","author":"Doehner","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0320","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid lowering treatment with benzbromarone in patients with heart failure: a double blind placebo-controlled cross-over preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0325","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0330","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00125-007-0817-7","article-title":"Lowering serum urate does not improve endothelial function in patients with type 2 diabetes","volume":"50","author":"Waring","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0335","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/hrt.2004.057190","article-title":"Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?","volume":"91","author":"Doehner","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13539-014-0154-x","article-title":"Cachexia: a problem of energetic inefficiency","volume":"5","author":"Argil\u00e9s","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0345","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0350","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0355","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clinthera.2012.12.011","article-title":"Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis","volume":"35","author":"Ye","year":"2013","journal-title":"Clin. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2015.08.089_bb0360","first-page":"ii15","article-title":"Febuxostat: a new treatment for hyperuricaemia in gout","volume":"48","author":"Edwards","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0365","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40292-014-0051-6","article-title":"Therapeutic approaches to chronic hyperuricemia and gout","volume":"21","author":"Grassi","year":"2014","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"10.1016\/j.ijcard.2015.08.089_bb0370","doi-asserted-by":"crossref","first-page":"e005354","DOI":"10.1136\/bmjopen-2014-005354","article-title":"Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia","volume":"4","author":"MacDonald","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0375","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13539-013-0116-8","article-title":"Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice","volume":"4","author":"Hinch","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2015.08.089_bb0380","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jcsm.12017","article-title":"Febuxostat improves outcome in a rat model of cancer cachexia","volume":"6","author":"Konishi","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T01:54:35Z","timestamp":1653011675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315303193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":76,"alternative-id":["S0167527315303193"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.089","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid and xanthine oxidase in heart failure \u2014 Emerging data and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}